Neural stem cell having increased passage ability, method for manufacturing neural stem cell having said increased passage abiility, and method for culturing neural stem cells for increasing passage ability of neural stem cells

US9574176B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9574176-B2
Application numberUS-201314436206-A
CountryUS
Kind codeB2
Filing dateOct 29, 2013
Priority dateOct 31, 2012
Publication dateFeb 21, 2017
Grant dateFeb 21, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides a neural stem cell having increased passage ability and a method for manufacturing a neural stem cell having increased passage ability. A neural stem cell in which the N-type calcium channel gene is knocked out or the influx of Ca2+ via the N-type calcium channel is substantially absent can be passaged for at least 4 generations and maintains the differentiation potential into a nerve cell even after passage for 4 generations.

First claim

Opening claim text (preview).

The invention claimed is: 1. A neural stem cell having the following characteristics: (a) function or expression of the N-type calcium channel is knocked out in the cell, (b) influx of Ca2+ via the N-type calcium channel is substantially absent when function or expression of the N-type calcium channel is knocked out in the cell, (c) the cell can be passaged for at least 4 generations, and (d) the cell maintains differentiation potential into a nerve cell after passage for 4 generations. 2. The neural stem cell according to claim 1 , wherein the gene encoding the α1B subunit of the N-type calcium channel is knocked out. 3. The neural stem cell according to claim 1 , wherein the neural stem cell is nestin-positive after passage for 4 generations. 4. The neural stem cell according to claim 1 , wherein the neural stem cell has high proliferation ability and high sphere-forming ability after passage for 4 generations. 5. The neural stem cell according to claim 1 , wherein function or expression of the N-type calcium channel is knocked out by contacting the neural stem cell with an agent that inhibits function or expression of the N-type calcium channel. 6. The neural stem cell according to claim 5 , wherein the agent is ω-conotoxin GVIA. 7. A method for manufacturing a neural stem cell, wherein the method comprises: (A) a step of preparing a neural stem cell in vitro, and (B) a step of knocking out function or expression of the N-type calcium channel of the neural stem cell in vitro, wherein the manufactured neural stem cell has the following characteristics: (a) function or expression of the N-type calcium channel is knocked out in the cell, (b) influx of Ca2+ via the N-type calcium channel is substantially absent when function or expression of the N-type calcium channel is knocked out in the cell, (c) the cell can be passaged for at least 4 generations, and (d) the cell maintains differentiation potential into a nerve cell after passage for 4 generations. 8. The method for manufacturing a neural stem cell according to claim 7 , wherein the neural stem cell in step (A) is a cell derived from a human. 9. The method for manufacturing a neural stem cell according to claim 7 , wherein the neural stem cell in step (A) is a neural stem cell prepared by differentiation induction of an embryonic stem (ES) or induced pluripotent stem (iPS) cell into a neural stem cell. 10. The method for manufacturing a neural stem cell according to claim 7 , wherein the gene encoding the α1B subunit of the N-type calcium channel is knocked out. 11. The method for manufacturing a neural stem cell according to claim 7 , wherein function or expression of the N-type calcium channel is knocked out by contacting the neural stem cell with an agent that inhibits function or expression of the N-type calcium channel. 12. The method for manufacturing a neural stem cell according to claim 11 , wherein the agent is ω-conotoxin GVIA.

Assignees

Inventors

Classifications

  • Cell cycle regulated proteins, e.g. cyclins, cyclin-dependant kinases · CPC title

  • Calcium; Ca chelators; Calcitonin · CPC title

  • Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells · CPC title

  • for animal cells · CPC title

  • C12N5/0623Primary

    Stem cells · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9574176B2 cover?
The present invention provides a neural stem cell having increased passage ability and a method for manufacturing a neural stem cell having increased passage ability. A neural stem cell in which the N-type calcium channel gene is knocked out or the influx of Ca2+ via the N-type calcium channel is substantially absent can be passaged for at least 4 generations and maintains the differentiation p…
Who is the assignee on this patent?
Eisai R&D Man Co Ltd
What technology area does this patent fall under?
Primary CPC classification C12N5/0623. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).